About Raptim Research Ltd

  Inspected by USFDA between 06th to 10th November 2017 and the inspection has concluded with Zero 483.

  The scope was In vitro Release Testing (IVRT) and In vitro Permeability Testing (IVPT) studies of Dermal product, CacO2 permeability studies and First to file product.

  Renovated clinical facility

Raptim Research Ltd. is a quality-oriented full-service contract (clinical) research organization. Raptim provides end-to-end services to global Pharmaceutical (generic as well as research-based), Biotechnology and Cosmetic industry. Raptim stands for “Rapid” and it acts as a catalyst to hasten the regulatory submissions and approvals of customers’ products.

Raptim Research Ltd., incorporated in the year 2005, has its facilities based in Navi Mumbai and Business Office in Navi Mumbai as well as New Jersey, USA.

Current Highlights

  • Recently, we successfully conducted Skin Blanching Study for Topical Corticosteroid Product
  • We have been inspected and certified for GCP and GLP Compliance   from ISP Chile
  • We have been successfully inspected by USFDA between 06th to 10th November 2017 and the inspection has concluded with Zero 483.
  • Expertise in respiratory segment – Developed and validated simultaneous bioanalytical method for Salmeterol and fluticasone with LLOQ of 1 pg/ml.
  • Also method is available for Beclomethasone, Budesonide, Salbutamol & Glycopyrrolate.
  • Expertise in Vitamin BE studies - Developed and validated method for Calcitriol (with LLOQ 2.5 pg/ml), Ergocalciferol and Phytonadione.
  • Expertise in BE studies of Narcotic Products – Submitted BE studies for Morphine, Buprenorphine + Naloxone, Methylphenidate etc.
  • Expertise in Dermatology Studies - in vitro skin permeation and mass balance using human Cadaver skin and others membrane, In Vivo of Tape Stripping and Microdialyis study, Skin Blanching study for Corticosteroids, irritation and sensitization study.